AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

HeartBeam Inc. (BEAT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.13

-0.05 (-2.29%)

At close: Feb 20, 2025, 3:59 PM

2.11

-0.71%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	2.02
Market Cap	56.66M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.68
PE Ratio (ttm)	-3.12
Forward PE	n/a
Analyst	Buy

Ask	2.26
Volume	107,805
Avg. Volume (20D)	178,266
Open	2.18
Previous Close	2.18
Day's Range	2.10 - 2.15
52-Week Range	1.35 - 3.48
Beta	undefined

About BEAT

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Nov 11, 2021

Employees 20

Stock Exchange NASDAQ

Ticker Symbol BEAT

Website https://www.heartbeam.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for BEAT stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 50.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

2 months ago

-13.14%

Heartbeam shares are trading lower amid a possible... Unlock content with Pro Subscription

News

1 week ago · businesswire.com

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock.

3 weeks ago · businesswire.com

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software.

2 months ago · businesswire.com

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference.

2 months ago · businesswire.com

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology.